Back to List/Filter


TBBO8520-101

NCT06343402

A Phase 1a/1b Open-Label Study of BBO-8520 Monotherapy and BBO-8520 in Combination With Pembrolizumab in Subjects With Advanced KRASG12C Mutant Non-Small Cell Lung Cancer - the ONKORAS-101 Study
The Queen Elizabeth Hospital (Haematology and Oncology)
28 Woodville Rd, Woodville South SA 5011, Australia
Recruiting
Primary Contact : Pamela Cooper, Pamela.cooper@sa.gov.au , 08 8222 6410
Secondary Contact : Tamara Olszowka, Tamara.Olszowka@sa.gov.au , 08 8222 8011

N/A

Interventional

Treatment - Drugs

Phase 1

18

100

11/09/2024

N/A

Open

By Specialist and/or Surgeon Referral,Primary Care or GP Referral

N/A

No

No

No
Oncology
Lung
Non Small Cell Lung Cancer
Other

24090032